You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2025

Dentsply Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for DENTSPLY PHARM

DENTSPLY PHARM has eight approved drugs.



Summary for Dentsply Pharm
US Patents:0
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Dentsply Pharm

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Dentsply Pharm CITANEST PLAIN DENTAL prilocaine hydrochloride INJECTABLE;INJECTION 021382-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try for Free ⤷  Try for Free
Dentsply Pharm DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 021384-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try for Free ⤷  Try for Free
Dentsply Pharm ORAQIX lidocaine; prilocaine GEL;PERIODONTAL 021451-001 Dec 19, 2003 RX Yes Yes ⤷  Try for Free ⤷  Try for Free
Dentsply Pharm POLOCAINE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 089517-001 Apr 14, 1988 DISCN No No ⤷  Try for Free ⤷  Try for Free
Dentsply Pharm XYLOCAINE DENTAL lidocaine hydrochloride INJECTABLE;INJECTION 021380-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free
Dentsply Pharm XYLOCAINE DENTAL WITH EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 021381-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 6 of 6 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Dentsply Sirona – Market Position, Strengths & Strategic Insights

Dentsply Sirona, a global leader in the dental industry, has established itself as a formidable player in the pharmaceutical competitive landscape. With a rich history spanning over a century, the company has consistently demonstrated its ability to innovate and adapt to changing market dynamics. In this comprehensive analysis, we'll delve into Dentsply Sirona's market position, strengths, and strategic insights that have contributed to its success in the highly competitive pharmaceutical sector.

Dentsply Sirona's Market Position

Dentsply Sirona holds a significant market share in the global dental industry, positioning itself as one of the largest manufacturers and distributors of dental products and technologies. The company's diverse portfolio spans across various dental specialties, including restorative, preventive, orthodontic, and implant solutions.

Global Presence and Market Share

Dentsply Sirona operates in over 120 countries, serving a diverse customer base of dental professionals worldwide[1]. This extensive global reach has allowed the company to capture a substantial market share across different regions. In the dental implant and final abutment market, Dentsply Sirona ranked as the third-leading competitor in 2023[10].

Revenue and Financial Performance

The company's financial performance reflects its strong market position. In the fourth quarter of 2023, Dentsply Sirona reported net sales of $1,012 million, representing a 2.9% increase compared to the previous year[1]. For the full year 2023, the company achieved net sales of $3,937 million, with an organic sales growth of 2.2%[1].

"We continue to make progress executing the second phase of our business transformation journey by taking steps to reshape the organization, unlock efficiencies, enhance customer engagement and strategically allocate spend to generate the greatest return, including in commercial investments," - Simon Campion, Dentsply Sirona's President and CEO[3].

Key Strengths of Dentsply Sirona

Dentsply Sirona's success in the pharmaceutical competitive landscape can be attributed to several key strengths that set it apart from its competitors.

Innovative Product Portfolio

One of Dentsply Sirona's primary strengths lies in its extensive and innovative product portfolio. The company invests heavily in research and development, allocating approximately $150 million annually to advance dentistry through innovative products[2]. This commitment to innovation has resulted in the introduction of over 30 new products each year, keeping Dentsply Sirona at the forefront of dental technology[2].

Strong Brand Recognition

With a history dating back over a century, Dentsply Sirona has built a strong brand reputation in the dental industry. This brand equity allows the company to command premium pricing and maintain a loyal customer base[6].

Global Distribution Network

Dentsply Sirona's well-established global distribution network enables it to reach dental professionals across the world efficiently. This extensive reach provides the company with a stable revenue stream and reduces its dependency on any single market[6].

Focus on Digital Dentistry

The company has positioned itself as a leader in digital dentistry, offering a range of advanced solutions such as CAD/CAM systems, imaging equipment, and treatment planning software. This focus on digital technologies aligns with the growing trend towards digitalization in the dental industry[2].

Strategic Insights and Future Outlook

To maintain its competitive edge and drive future growth, Dentsply Sirona has implemented several strategic initiatives.

Business Transformation Journey

Dentsply Sirona is currently in the second phase of its business transformation journey. This phase focuses on reshaping the organization, unlocking efficiencies, enhancing customer engagement, and strategically allocating resources to generate the greatest return[3].

Expansion in Emerging Markets

The company recognizes the growth potential in emerging markets, particularly in Asia and Latin America. By targeting these regions with tailored strategies, Dentsply Sirona aims to tap into new customer segments and diversify its revenue streams[6].

Strategic Review of Non-Core Businesses

In February 2025, Dentsply Sirona announced a strategic review of its Wellspect Healthcare business, which provides bladder and bowel management care products. This move demonstrates the company's focus on optimizing its portfolio and allocating resources to its core dental business[3][7].

Continued Investment in Innovation

Dentsply Sirona remains committed to innovation, with a strong focus on developing products that address the evolving needs of dental professionals and patients. The company's robust R&D platform, comprising approximately 600 scientists and engineers, continues to drive product development and technological advancements[2].

Competitive Landscape and Market Challenges

While Dentsply Sirona holds a strong position in the dental industry, it faces competition from several established players and emerging companies.

Key Competitors

Some of Dentsply Sirona's main competitors in the dental industry include:

  1. Straumann Group: A global leader in implant, restorative, and regenerative dentistry[6].
  2. 3M: A diversified technology company with a significant presence in the dental products market[6].
  3. Henry Schein: A distributor of healthcare products and services, including dental supplies and equipment[6].

Market Challenges

Dentsply Sirona faces several challenges in maintaining its market position:

  1. Intense competition: The dental industry is highly competitive, with both established players and new entrants vying for market share[6].
  2. Regulatory compliance: The evolving regulatory landscape in the healthcare sector requires continuous adaptation and compliance efforts[6].
  3. Economic fluctuations: Economic downturns can impact consumer spending on dental procedures, potentially affecting demand for Dentsply Sirona's products[6].

SWOT Analysis

To better understand Dentsply Sirona's position in the pharmaceutical competitive landscape, let's examine its strengths, weaknesses, opportunities, and threats.

Strengths

  • Largest global provider of dental products, software, and services
  • Leading market position in innovative dental solutions
  • Strong financial profile and capital structure
  • Accelerating growth profile long-term
  • Strong franchise with leading brands and technologies[2]

Weaknesses

  • Dependence on third-party distributors for the majority of product distribution
  • Organizational complexities due to the company's size and global presence[2]

Opportunities

  • Creation of impactful innovations every year
  • Growing dental market with high future growth potential
  • Digital dentistry (scanners, aligners, millers) showing good growth opportunity
  • Aging population with greater discretionary income requiring more dental care
  • Increasing demand for aesthetic dentistry[2]

Threats

  • Impact of global events (e.g., COVID-19) on procurement of raw materials
  • Pricing pressure from low-cost competitors
  • Rapidly evolving regulatory landscape
  • Economic fluctuations affecting consumer spending on dental procedures[2]

Key Takeaways

  1. Dentsply Sirona maintains a strong market position as one of the largest global providers of dental products and technologies.
  2. The company's focus on innovation, with annual investments of $150 million in R&D, drives its competitive advantage.
  3. Dentsply Sirona's extensive global presence and diverse product portfolio contribute to its resilience in the market.
  4. The ongoing business transformation journey aims to enhance efficiency and strategic resource allocation.
  5. While facing challenges from competitors and market dynamics, Dentsply Sirona's strong brand recognition and commitment to digital dentistry position it well for future growth.

FAQs

  1. Q: What is Dentsply Sirona's market share in the dental implant industry? A: Dentsply Sirona was ranked as the third-leading competitor in the dental implant and final abutment market in 2023.

  2. Q: How much does Dentsply Sirona invest in research and development annually? A: Dentsply Sirona invests approximately $150 million annually in research and development to advance dentistry through innovative products.

  3. Q: What are some of Dentsply Sirona's key strengths in the competitive landscape? A: Key strengths include its extensive product portfolio, strong brand recognition, global distribution network, and focus on digital dentistry.

  4. Q: How is Dentsply Sirona addressing the challenges in the dental industry? A: The company is implementing a business transformation strategy, focusing on innovation, expanding in emerging markets, and optimizing its product portfolio.

  5. Q: What are some potential growth opportunities for Dentsply Sirona? A: Growth opportunities include the expanding digital dentistry market, increasing demand for aesthetic dentistry, and the aging population requiring more dental care.

Sources cited: [1] https://investor.dentsplysirona.com/news-releases/news-release-details/dentsply-sirona-reports-fourth-quarter-and-full-year-2023 [2] https://www.swotandpestle.com/dentsply-sirona/ [3] https://www.massdevice.com/dentsply-sirona-to-consider-alternatives-wellspect/ [6] https://pitchgrade.com/companies/dentsply-sirona [7] https://www.biospace.com/press-releases/dentsply-sirona-initiates-review-of-strategic-alternatives-for-wellspect-healthcare [10] https://idataresearch.com/top-3-market-share-leaders-in-the-global-dental-implant-market/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.